I am a breastfeeding mother and i want to know if it is safe to use EINECS 223-110-2? Is EINECS 223-110-2 safe for nursing mother and child? Does EINECS 223-110-2 extracts into breast milk? Does EINECS 223-110-2 has any long term or short term side effects on infants? Can EINECS 223-110-2 influence milk supply or can EINECS 223-110-2 decrease milk supply in lactating mothers?
- DrLact safety Score for EINECS 223-110-2 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of EINECS 223-110-2 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that EINECS 223-110-2 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of EINECS 223-110-2 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding.
EINECS 223-110-2 is sometimes found in the plasma of nursing infants at levels of 7.5-12.5% of the mother's levels. The N-monodesalkylEINECS 223-110-2 (NMD) metabolite is more anticholinergic than EINECS 223-110-2 itself and appears in breastmilk in levels higher than EINECS 223-110-2. However, of the cases reported, there are no reports of infant effects. EINECS 223-110-2 may be used cautiously while breastfeeding when other alternatives are unacceptable. Observe the infant for anticholinergic symptoms. Infant serum concentrations can be monitored if there is any concern about drug-induced adverse effects. Theoretically, EINECS 223-110-2 might decrease the milk supply.
There are reports of 2 infants who were breastfed without complications during maternal EINECS 223-110-2 use of 500 to 600 mg daily.[1][2] Infant symptoms of crying and restlessness after meals thought by one mother to be caused by EINECS 223-110-2 in breastmilk were judged to be unrelated by the examining physicians.[3]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.